Latest GM & Biosafety Resources

S’attaquer aux risques, au battage médiatique et aux inégalités qui sous-tendent la biologie générative Click here for the English version. Haga clic aquí para la versión en español. Le Centre africain pour la biodiversité (ACB), en collaboration avec le Réseau Tiers-monde (TWN) et l’ETC Group, a produit une note d’information opportune avant la 16e réunion […]

Afrontar los riesgos, exageraciones y desigualdades de la biología generativa Click here for the English version. Cliquez ici pour la version française. El Centro Africano para la Biodiversidad (ACB), junto con la Third World Network (TWN) y el ETC Group, han elaborado un oportuno documento informativo de cara a la 16ª reunión de la Conferencia […]

Addressing the risks, hype, and inequities underpinning generative biology Haga clic aquí para la versión en español. Cliquez ici pour la version française. The African Centre for Biodiversity (ACB), together with Third World Network (TWN) and ETC Group, have produced a timely briefing paper ahead of the 16th meeting of the Conference of the Parties […]

DISASTER CAPITALISM, BIOTECH INDUSTRY IN DECLINE & INSTRUMENTALISATION OF WHEAT IN AFRICA In August 2022, the South African government approved a GM wheat variety HB4 for importation as food, feed, and for the purposes of industrial food and feed processing, following Nigeria’s approval in July. Since then, Argentina and Brazil have been the only two […]

The case for categorising 2,4-D as a highly hazardous pesticide in South Africa In December 2019, three genetically modified (GM maize) varieties developed by Corteva (formally Dow AgroSciences) – genetically engineered to tolerate the toxic and highly hazardous chemical 2,4-D – were approved for commercial cultivation in South Africa, despite many long years of opposition […]

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

(Por favor clique aqui para Português) (Veuillez cliquer ici pour le français) African food sovereignty movement’s victory over, and continued resistance against, the biotech industry Despite two decades of biotech industry-backed lobbying, funding, relentless propaganda and backroom deals, supported by neo-colonial philanthropy-capitalists, such as Bill Gates; this machinery has very little to show. Only 2.9 […]

Regulatory issues and threats for Africa Veuillez cliquer ici pour le français Clique aqui para a versão portuguesa Por favor, haga clic aquí para el español Genome editing risks aggravating the problems of industrial agriculture, prolonging a model that threatens both human health and the environment, and further opens up African food systems to hegemonic […]

Transition to agroecology urgently needed This paper aims to update the public on activities and increased concerns since South Africa first approved the cultivation of genetically modified (GM) crops before the turn of the century. We are now living through a global pandemic, pointing to the imbalanced relationship between humans and our life-supporting systems and […]

Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]

(Cliquez ici pour le français) Conducted silently and out of the public eye, a three-year experiment involving a new and potentially unsafe and risky genetically modified (GM) fungus to kill mosquitoes was performed in the village of Soumousso in Burkina Faso in 2019. When the study was published in a US scientific journal in May […]

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]